Loading
The radiation oncologist who is chief medical officer of the New York Proton Center, the proton therapy centre founded by Memorial Sloan Kettering, Montefiore and Mount Sinai.
Charles Simone is Chief Medical Officer of the New York Proton Center, which its leadership page lists alongside Chief Executive Officer Christopher Panczner and Director of Medical Physics Haibo Lin. The centre was created through a partnership of three academic medical centres, Memorial Sloan Kettering Cancer Center, Montefiore and Mount Sinai, and describes itself as the first and only proton therapy centre in New York. His research concerns proton therapy for lung and other thoracic cancers and the comparative evidence for particle therapy. His publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial | JAMA Oncology | 2023 |
| Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline | Journal of Clinical Oncology | 2022 |
| Spatially fractionated radiation therapy: History, present and the future | Clinical and Translational Radiation Oncology | 2020 |
These papers come from a Europe PMC search on the author's name and institution, taking the most cited articles.
Shares Proton therapy and the tag leadership.
Shares Proton therapy and the tag leadership.
Shares Proton therapy and the tag leadership.
Shares Proton therapy and the tag leadership.
Shares Proton therapy, Non-small-cell lung cancer.
Shares Non-small-cell lung cancer and the tag leadership.
Shares Non-small-cell lung cancer and the tag leadership.
Shares Non-small-cell lung cancer and the tag leadership.